These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35117466)

  • 1. Clinicopathological significance and prognostic implication of CD44 and its splice variants (v3 and v6) in colorectal cancer.
    Yan B; Mu Y; Cui M; Liu L
    Transl Cancer Res; 2020 Feb; 9(2):1215-1224. PubMed ID: 35117466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints.
    Wibulswas A; Croft D; Pitsillides AA; Bacarese-Hamilton I; McIntyre P; Genot E; Kramer IM
    Arthritis Rheum; 2002 Aug; 46(8):2059-64. PubMed ID: 12209509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity.
    Crispín JC; Keenan BT; Finnell MD; Bermas BL; Schur P; Massarotti E; Karlson EW; Fitzgerald LM; Ergin S; Kyttaris VC; Tsokos GC; Costenbader KH
    Arthritis Rheum; 2010 May; 62(5):1431-7. PubMed ID: 20213807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy.
    Aaltomaa S; Lipponen P; Viitanen J; Kankkunen JP; Ala-Opas M; Kosma VM
    Eur Urol; 2000 Nov; 38(5):555-62. PubMed ID: 11096236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.
    Zhao LH; Lin QL; Wei J; Huai YL; Wang KJ; Yan HY
    Int J Clin Exp Pathol; 2015; 8(1):692-701. PubMed ID: 25755763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis.
    Wang Z; Tang Y; Xie L; Huang A; Xue C; Gu Z; Wang K; Zong S
    Front Oncol; 2019; 9():309. PubMed ID: 31114754
    [No Abstract]   [Full Text] [Related]  

  • 8. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
    Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
    J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
    Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
    Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
    Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
    Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma: a multicenter study.
    Hefler LA; Concin N; Mincham D; Thompson J; Swarte NB; van Eijkeren MA; Sie-Go DM; Hammond I; McCartney AJ; Tempfer CB; Speiser P
    Cancer; 2002 Jan; 94(1):125-30. PubMed ID: 11815968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of CD44s, CD44v3 and CD44v6 in breast cancer.
    Wu XJ; Li XD; Zhang H; Zhang X; Ning ZH; Yin YM; Tian Y
    J Int Med Res; 2015 Apr; 43(2):173-9. PubMed ID: 25571897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
    Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
    Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of CD44 isoform expression in endometrial cancer.
    Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C
    Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 splice variants as prognostic markers in colorectal cancer.
    Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
    Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.
    Afify A; Pang L; Howell L
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):446-50. PubMed ID: 18091389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer.
    Aaltomaa S; Lipponen P; Ala-Opas M; Kosma VM
    Eur Urol; 2001 Feb; 39(2):138-44. PubMed ID: 11223672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C
    Ejima R; Suzuki H; Tanaka T; Asano T; Kaneko MK; Kato Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.